FDA approves UCB's drug to treat epilepsy-related seizures

February 19, 2016 2:50 PM

6 0

The U.S. Food and Drug Administration (FDA) approved Belgian drugmaker UCB SA's drug as an add-on therapy to treat partial seizures caused by epilepsy.

The FDA approval comes nearly two months after the European health regulators recommended approval of the drug, Briviact, in Europe.

Read more

To category page

Loading...